Several mutations, including those in BRCA1, BRCA2, ATM, CHEK2, and PALB2, have been associated with the clinicopathological features exemplified by the breast cancer subtype and tissue of origin for additional cancers1,4. This evidence concerns the gene PALB2 and breast carcinoma.